Rohan Chaubal
Overview
Explore the profile of Rohan Chaubal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghosh A, Chaubal R, Das C, Parab P, Das S, Maitra A, et al.
Commun Biol
. 2025 Feb;
8(1):207.
PMID: 39930151
ER/PR+HER2- breast tumours are the most predominant subtype of breast cancer worldwide, including India. Unlike TNBCs, these tumours can be treated with anti-estrogens or aromatase inhibitors. Despite the success of...
2.
Chaubal R, Gardi N, Joshi S, Pantvaidya G, Kadam R, Vanmali V, et al.
Mol Cancer Res
. 2024 Feb;
22(6):572-584.
PMID: 38394149
Implications: Surgery deregulates hallmarks of cancer in human tissue.
3.
Gardi N, Chaubal R, Parab P, Pachakar S, Kulkarni S, Shet T, et al.
Cancer Res Commun
. 2024 Feb;
4(2):404-417.
PMID: 38315150
Significance: In germline BRCA1 mutated and BRCA wild-type patients, TNBC shows a branching evolutionary pattern of mutations with a single founding clone, are polyclonal throughout their disease course, and have...
4.
Butti R, Kapse P, Bhadauriya G, Ahmad S, Chaubal R, Parab P, et al.
Oncol Rep
. 2023 Mar;
49(5).
PMID: 36999625
Numerous years of cell line‑based studies have enhanced the current understanding of cancer and its treatment. However, limited success has been achieved in treating hormone receptor‑positive, HER2‑negative metastatic breast cancers...
5.
Chatterjee S, Chaubal R, Maitra A, Gardi N, Dutt A, Gupta S, et al.
Breast Cancer Res Treat
. 2018 Mar;
170(2):431-438.
PMID: 29564740
Purpose: We have reported a survival benefit of single injection of hydroxyprogesterone prior to surgery for primary tumour in patients with node-positive operable breast cancer. Hydroxyprogesterone was meant to recapitulate...
6.
Mittra I, Samant U, Sharma S, Raghuram G, Saha T, Tidke P, et al.
Cell Death Discov
. 2017 Jun;
3:17015.
PMID: 28580170
Bystander cells of the tumor microenvironment show evidence of DNA damage and inflammation that can lead to their oncogenic transformation. Mediator(s) of cell-cell communication that brings about these pro-oncogenic pathologies...
7.
Kaur E, Sahu A, Hole A, Rajendra J, Chaubal R, Gardi N, et al.
Sci Rep
. 2016 May;
6:26538.
PMID: 27221528
An inability to discern resistant cells from bulk tumour cell population contributes to poor prognosis in Glioblastoma. Here, we compared parent and recurrent cells generated from patient derived primary cultures...
8.
Chandrani P, Upadhyay P, Iyer P, Tanna M, Shetty M, Raghuram G, et al.
BMC Genomics
. 2015 Nov;
16:936.
PMID: 26572163
Background: Several statistical tools have been developed to identify genes mutated at rates significantly higher than background, indicative of positive selection, involving large sample cohort studies. However, studies involving smaller...
9.
Barreto S, Barreto M, Chaubal R, Dutt A
Indian J Med Paediatr Oncol
. 2015 Jul;
36(2):85-6.
PMID: 26157283
This article alludes to the findings of Tomasetti and Vogelstein and argues that for clinicians and scientists no matter how difficult understanding the pathogenesis of cancer may be, they remain...
10.
Mittra I, Khare N, Raghuram G, Chaubal R, Khambatti F, Gupta D, et al.
J Biosci
. 2015 Mar;
40(1):91-111.
PMID: 25740145
Whether nucleic acids that circulate in blood have any patho-physiological functions in the host have not been explored.We report here that far from being inert molecules, circulating nucleic acids have...